/Investor DB

Northpond Ventures — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

908 Devices908devices.comin𝕏NASDAQ: MASSApr 2019 · $18M

908 Devices manufactures handheld mass spectrometry and chemical analysis devices for rapid detection in defense, security, and hazardous materials response applications.

Deep TechDefense TechHardwareMedical DevicesBoston, US

Kevin J. Knopp, PhD(CEO & Co-founder)Christopher Brown(Executive Officer)inKevin Knopp(Executive Officer, Director)inJoseph Griffith IV(Executive Officer)

BoardKevin Hrusovsky(Director)Corey Steffek(Director)

Board seatSharon Kedar· per SEC Form D

Co-investorsARCH Venture PartnersCasdin CapitalHercules Capital, Inc.In-Q-TelRazor's Edge VenturesUTEC+5 more

Ultivueultivue.comin𝕏Series C · Jun 2019 · $22M✓ verifiedAcquired

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Board seatSharon Kedar· per SEC Form D

Co-investorsARCH Venture Partners6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova CapitalPura Vida Investments+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Emulate, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.